INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 112 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $365,331 | -16.8% | 16,324 | +2.3% | 0.00% | – |
Q1 2024 | $438,951 | +36.3% | 15,956 | +51.1% | 0.00% | – |
Q4 2023 | $322,005 | +198.6% | 10,561 | +209.7% | 0.00% | – |
Q3 2023 | $107,824 | -29.8% | 3,410 | -9.5% | 0.00% | – |
Q2 2023 | $153,618 | +17.5% | 3,767 | +7.4% | 0.00% | – |
Q1 2023 | $130,707 | +6.1% | 3,507 | -0.7% | 0.00% | – |
Q4 2022 | $123,233 | -37.8% | 3,532 | +1.0% | 0.00% | – |
Q3 2022 | $198,000 | +9.4% | 3,497 | -0.5% | 0.00% | – |
Q2 2022 | $181,000 | -67.0% | 3,514 | -53.5% | 0.00% | – |
Q1 2022 | $549,000 | -67.5% | 7,557 | -47.1% | 0.00% | -100.0% |
Q4 2021 | $1,691,000 | -29.2% | 14,297 | -19.7% | 0.00% | -50.0% |
Q3 2021 | $2,389,000 | -20.6% | 17,810 | -4.2% | 0.00% | -33.3% |
Q2 2021 | $3,010,000 | +102.1% | 18,592 | +0.2% | 0.00% | +200.0% |
Q1 2021 | $1,489,000 | +49.2% | 18,556 | +1.1% | 0.00% | 0.0% |
Q4 2020 | $998,000 | +275.2% | 18,358 | +37.4% | 0.00% | – |
Q3 2020 | $266,000 | 0.0% | 13,358 | +5.2% | 0.00% | – |
Q2 2020 | $266,000 | -4.3% | 12,700 | -44.1% | 0.00% | – |
Q1 2020 | $278,000 | -5.4% | 22,700 | +13.5% | 0.00% | – |
Q4 2019 | $294,000 | +145.0% | 20,000 | +121.0% | 0.00% | – |
Q3 2019 | $120,000 | -26.8% | 9,050 | -9.5% | 0.00% | – |
Q2 2019 | $164,000 | -8.4% | 10,000 | -4.6% | 0.00% | – |
Q1 2019 | $179,000 | +31.6% | 10,485 | +4.8% | 0.00% | – |
Q4 2018 | $136,000 | +6700.0% | 10,000 | +9900.0% | 0.00% | – |
Q3 2017 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q2 2017 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q4 2016 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q3 2016 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q2 2016 | $2,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |